Literature DB >> 20732335

Selective deficits in spatial working memory in the neonatal ventral hippocampal lesion rat model of schizophrenia.

Anne Marie Brady1, Ronald D Saul, Matthew K Wiest.   

Abstract

The neonatal ventral hippocampal lesion (NVHL) manipulation is a neurodevelopmental animal model of schizophrenia that produces abnormalities in the prefrontal cortex and nucleus accumbens, both efferent targets of the hippocampus, and leads to spatial working memory impairments. To investigate the neuroanatomical basis of spatial working memory in NVHL animals, we assessed performance in two radial arm maze tasks known to be differentially sensitive to the two hippocampal efferent pathways, and measured levels of neuronal activation (Fos immunoreactivity [Fos-IR]) in the prefrontal cortex and nucleus accumbens following task performance. Neonatal rats (postnatal day 6-8) received excitotoxic lesions of the ventral hippocampus (n=25), or a sham procedure (infusions of artificial cerebrospinal fluid; n=22). Upon reaching adulthood, animals were trained in either a non-delayed random foraging task or a spatial delayed win-shift task. NVHL animals were impaired on the spatial delayed win-shift task, which depends on communication between hippocampus and prefrontal cortex, but were unimpaired on the non-delayed random foraging task, which requires connections between hippocampus and nucleus accumbens. Fos-IR in the nucleus accumbens was greater in NVHL animals than in shams following the random foraging task, despite similar levels of performance, while no group differences in Fos-IR in either the nucleus accumbens or prefrontal cortex were observed following win-shift performance. These results suggest that although the NVHL manipulation disrupts development of hippocampal efferents to both the prefrontal cortex and the nucleus accumbens, the disruption of hippocampal-prefrontal pathways has the dominant behavioral effect on spatial performance in NVHL rats.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20732335     DOI: 10.1016/j.neuropharm.2010.08.012

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  15 in total

1.  Transgenic mice overexpressing the extracellular domain of NCAM are impaired in working memory and cortical plasticity.

Authors:  Leann H Brennaman; Gaga Kochlamazashvili; Luminita Stoenica; Randall J Nonneman; Sheryl S Moy; Melitta Schachner; Alexander Dityatev; Patricia F Maness
Journal:  Neurobiol Dis       Date:  2011-04-16       Impact factor: 5.996

2.  Transient inactivation of the neonatal ventral hippocampus permanently disrupts the mesolimbic regulation of prefrontal cholinergic transmission: implications for schizophrenia.

Authors:  Julie M Brooks; Martin Sarter; John P Bruno
Journal:  Neuropsychopharmacology       Date:  2011-08-03       Impact factor: 7.853

3.  Nonsteroidal anti-inflammatory treatment prevents delayed effects of early life stress in rats.

Authors:  Heather C Brenhouse; Susan L Andersen
Journal:  Biol Psychiatry       Date:  2011-06-16       Impact factor: 13.382

Review 4.  Animal models of schizophrenia.

Authors:  C A Jones; D J G Watson; K C F Fone
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

5.  Role of presynaptic phosphoprotein synapsin II in schizophrenia.

Authors:  Luke Molinaro; Patricia Hui; Mattea Tan; Ram K Mishra
Journal:  World J Psychiatry       Date:  2015-09-22

6.  Mutation of Dcdc2 in mice leads to impairments in auditory processing and memory ability.

Authors:  D T Truong; A Che; A R Rendall; C E Szalkowski; J J LoTurco; A M Galaburda; R Holly Fitch
Journal:  Genes Brain Behav       Date:  2014-09-03       Impact factor: 3.449

7.  Transient inactivation of the neonatal ventral hippocampus impairs attentional set-shifting behavior: reversal with an α7 nicotinic agonist.

Authors:  Julie M Brooks; Michelle L Pershing; Morten S Thomsen; Jens D Mikkelsen; Martin Sarter; John P Bruno
Journal:  Neuropsychopharmacology       Date:  2012-07-11       Impact factor: 7.853

8.  Hyper-response to Novelty Increases c-Fos Expression in the Hippocampus and Prefrontal Cortex in a Rat Model of Schizophrenia.

Authors:  Tomas Monfil; Rubén Antonio Vázquez Roque; Israel Camacho-Abrego; Hiram Tendilla-Beltran; Tommaso Iannitti; Ivan Meneses-Morales; Patricia Aguilar-Alonso; Gonzalo Flores; Julio Cesar Morales-Medina
Journal:  Neurochem Res       Date:  2017-12-06       Impact factor: 3.996

9.  Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophrenia.

Authors:  Dan Shan; Elizabeth K Lucas; Jana B Drummond; Vahram Haroutunian; James H Meador-Woodruff; Robert E McCullumsmith
Journal:  Schizophr Res       Date:  2013-01-26       Impact factor: 4.939

10.  Early developmental elevations of brain kynurenic acid impair cognitive flexibility in adults: reversal with galantamine.

Authors:  K S Alexander; A Pocivavsek; H-Q Wu; M L Pershing; R Schwarcz; J P Bruno
Journal:  Neuroscience       Date:  2013-02-06       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.